Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 15, 2025 |
| Target | Aculys Pharma |
| Sector | Life Science |
| Buyer(s) | Viatris |
| Sellers(s) | HBM Partners |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1961 |
| Sector | Life Science |
| Employees | 32,000 |
| Revenue | 14.7B USD (2024) |
Viatris is a generic and specialty pharmaceutical company. Viatris offers the industry's broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Viatris was founded in 1961 and is based in Canonsburg, Pennsylvania.
| Deal Context for Buyer | # |
|---|---|
| Overall | 14 of 14 |
| Sector: Life Science | 11 of 11 |
| Type: Add-on Acquisition | 5 of 5 |
| Country: Japan | 1 of 1 |
| Year: 2025 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-18 |
Viatris - Unit Dose Laboratories
Canonsburg, Pennsylvania, United States Viatris' Unit Dose Laboratories provides unit-dose generic medicines to institutional and long-term care facilities. Viatris' Unit Dose Laboratories was founded in 1980 and is based in Canonsburg, Pennsylvania. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| Deal Context for Seller | # |
|---|---|
| Overall | 39 of 40 |
| Sector: Life Science | 35 of 35 |
| Type: Add-on Acquisition | 7 of 7 |
| Country: Japan | 1 of 1 |
| Year: 2025 | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-03-21 |
Visen Pharma
Shanghai, China Visen Pharma is a biopharmaceutical company focused on endocrine-related treatments. It is committed to providing more humane and innovative therapies to enable endocrine patients to enjoy better treatment processes and efficacy, achieving their desired lives. Visen Pharma was founded in 2018 and is based in Shanghai, China. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-12-15 |
Swixx Biopharma
Baar, Switzerland Swixx BioPharma is a specialized distributor of rare diseases, Rx and OTC medicinal products in Central & Eastern Europe, and acts as a true commercialization partner for Biotech & Pharma companies in this area. Swixx Biopharma was founded in 2014 and is based in Baar, Switzerland. |
Sell | - |
